Jeffrey H. Cooper, SVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 49,720 shares at $37.53 ($1.9M) on 2008-02-29, disclosed to the SEC on 2008-03-04.
Open-market sale of $1.9M BMRN by SVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.53 | 1,100 | $41K | 2.2% |
| 2 | $37.55 | 400 | $15K | 0.8% |
| 3 | $37.56 | 7,400 | $278K | 14.9% |
| 4 | $37.57 | 8,900 | $334K | 17.9% |
| 5 | $37.58 | 3,350 | $126K | 6.7% |
| 6 | $37.59 | 525 |
| $20K |
| 1.1% |
| 7 | $37.60 | 10,800 | $406K | 21.7% |
| 8 | $37.61 | 1,666 | $63K | 3.4% |
| 9 | $37.62 | 1,208 | $45K | 2.4% |
| 10 | $37.63 | 200 | $8K | 0.4% |
| 11 | $37.64 | 33 | $1K | 0.1% |
| 12 | $37.65 | 2,381 | $90K | 4.8% |
| 13 | $37.66 | 700 | $26K | 1.4% |
| 14 | $37.67 | 900 | $34K | 1.8% |
| 15 | $37.68 | 1,900 | $72K | 3.8% |
| 16 | $37.69 | 1,017 | $38K | 2.0% |
| 17 | $37.70 | 883 | $33K | 1.8% |
| 18 | $37.72 | 557 | $21K | 1.1% |
| 19 | $37.73 | 100 | $4K | 0.2% |
| 20 | $37.74 | 100 | $4K | 0.2% |
| 21 | $37.75 | 1,400 | $53K | 2.8% |
| 22 | $37.76 | 1,100 | $42K | 2.2% |
| 23 | $37.77 | 2,300 | $87K | 4.6% |
| 24 | $37.78 | 500 | $19K | 1.0% |
| 25 | $37.79 | 300 | $11K | 0.6% |
| Total | $37.62 avg | 49,720 | $1.9M | 100% |
| Filing → |
| BMRN | SELL | 2012-01-05 | $87K | — | Filing → |
| BMRN | SELL | 2011-11-03 | $83K | — | Filing → |
| BMRN | SELL | 2011-10-11 | $625K | — | Filing → |